| Primary |
| Hypothyroidism |
75.0% |
| Primary Hypothyroidism |
25.0% |
|
| Supraventricular Extrasystoles |
50.0% |
| Foetal Heart Rate Deceleration Abnormality |
25.0% |
| Weight Increased |
25.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
19.5% |
| Product Used For Unknown Indication |
16.5% |
| Asthma |
13.4% |
| Hypothyroidism |
12.8% |
| Migraine |
5.5% |
| Osteoarthritis |
5.5% |
| Depression |
3.7% |
| Major Depression |
3.0% |
| Ill-defined Disorder |
2.4% |
| Immunosuppressant Drug Therapy |
2.4% |
| Arthritis |
1.8% |
| Deep Vein Thrombosis |
1.8% |
| Epilepsy |
1.8% |
| Hypercholesterolaemia |
1.8% |
| Insomnia |
1.8% |
| Anxiety |
1.2% |
| Bursitis |
1.2% |
| Chronic Obstructive Pulmonary Disease |
1.2% |
| Gastrooesophageal Reflux Disease |
1.2% |
| Hypertension |
1.2% |
|
| Loss Of Consciousness |
25.0% |
| Dyspnoea |
8.3% |
| Skin Papilloma |
8.3% |
| Haemoptysis |
5.6% |
| Polyneuropathy |
5.6% |
| Tremor |
5.6% |
| Urinary Tract Infection |
5.6% |
| Blood Thyroid Stimulating Hormone Increased |
2.8% |
| Cerebral Haemorrhage |
2.8% |
| Gestational Diabetes |
2.8% |
| Hyperkalaemia |
2.8% |
| Oedema |
2.8% |
| Palpitations |
2.8% |
| Pancreatitis |
2.8% |
| Pneumonia |
2.8% |
| Pruritus |
2.8% |
| Pruritus Generalised |
2.8% |
| Skin Burning Sensation |
2.8% |
| Status Epilepticus |
2.8% |
| Throat Tightness |
2.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
25.7% |
| Drug Use For Unknown Indication |
20.0% |
| Rheumatoid Arthritis |
9.0% |
| Hypothyroidism |
8.5% |
| Hypertension |
6.3% |
| Depression |
3.1% |
| Thyroid Disorder |
2.8% |
| Pain |
2.7% |
| Primary Hypothyroidism |
2.5% |
| Diabetes Mellitus |
2.3% |
| Osteoporosis |
2.3% |
| Acth Decreased |
2.2% |
| Breast Cancer |
2.0% |
| Hypopituitarism |
1.8% |
| Myocardial Ischaemia |
1.7% |
| Atrial Fibrillation |
1.6% |
| Blood Cholesterol Increased |
1.5% |
| Schizophrenia |
1.5% |
| Systemic Lupus Erythematosus |
1.4% |
| Epilepsy |
1.3% |
|
| Vomiting |
13.3% |
| Weight Decreased |
8.2% |
| Respiratory Failure |
6.4% |
| Syncope |
6.4% |
| Urinary Tract Infection |
6.4% |
| Dyspnoea |
4.7% |
| Renal Impairment |
4.7% |
| Visual Acuity Reduced |
4.7% |
| Malaise |
4.3% |
| Pyrexia |
4.3% |
| Swelling Face |
4.3% |
| Paraesthesia |
3.9% |
| Weight Increased |
3.9% |
| Withdrawal Syndrome |
3.9% |
| Death |
3.4% |
| Nausea |
3.4% |
| Pain |
3.4% |
| Pain In Extremity |
3.4% |
| Pituitary Tumour |
3.4% |
| Pulmonary Embolism |
3.4% |
|
| Interacting |
| Drug Use For Unknown Indication |
71.4% |
| Obesity |
14.3% |
| Abdominal Pain Upper |
4.8% |
| Bladder Disorder |
4.8% |
| Post Procedural Hypothyroidism |
4.8% |
|
| Psychiatric Symptom |
33.3% |
| Inhibitory Drug Interaction |
16.7% |
| Psychotic Disorder |
16.7% |
| Temperature Intolerance |
16.7% |
| Weight Increased |
16.7% |
|
